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Abstract: Triclosan (TCS) is a multi-purpose antimicrobial agent used as a common 
ingredient in everyday household personal care and consumer products. The expanded use 
of TCS provides a number of pathways for the compound to enter the environment and it 
has been detected in sewage treatment plant effluents; surface; ground and drinking water. 
The physico-chemical properties indicate the bioaccumulation and persistence potential of 
TCS in the environment. Hence, there is an increasing concern about the presence of TCS 
in the environment and its potential negative effects on human and animal health. 
Nevertheless, scarce monitoring data could be one reason for not prioritizing TCS as emerging 
contaminant. Conventional water and wastewater treatment processes are unable to 
completely remove the TCS and even form toxic intermediates. Considering the worldwide 
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application of personal care products containing TCS and inefficient removal and its toxic 
effects on aquatic organisms, the compound should be considered on the priority list of 
emerging contaminants and its utilization in all products should be regulated. 
Keywords: degradation by-products; dioxins; emerging contaminants; personal care products; 
triclosan; toxicity 
 
1. Introduction 
Triclosan (TCS, 5-chloro-2-(2,4-dichlorophenoxy) phenol) is a synthetic, broad-spectrum 
antimicrobial agent. It has antibiotic and antimycotic properties [1]. Triclosan also blocks fatty acid 
synthesis by inhibiting enoyl reductase enzyme. TCS is categorized as a halogenated aromatic 
hydrocarbon having phenolic, diphenyl ether and polychlorinated biphenyl (PCB) substructures [2]. Its 
chemical structure is a halogenated biphenyl ether which confers it chemical properties related to many 
toxic compounds such as PCBs, polybrominated diphenyl ethers, bispenol A and dioxins [3].  
The worldwide annual production of TCS in 1998 was approximately 1500 tonnes, out of which 
about 350 tonnes and more than 450 tonnes were utilized in Europe and USA, respectively [4,5]. The 
main release of TCS into the environment is due to personal care products containing around 0.1% to 
0.3% (w/w) TCS [6,7]. Such products are externally applied to the human body, thus TCS is generally 
not subjected to metabolic alteration. Moreover, it is usually released into the domestic wastewater, thus 
ending up in local wastewater treatment plants (WWTP). Poor solubility and high adsorption of TCS to 
solids results in its removal from WWTP effluent up to 99%. [8,9]. The high log Kow value of 4.76 for 
TCS suggests high sorption potential and it adsorbs onto the settled sewage sludge [10,11] which may 
be amended to agricultural soils [12,13]. Thus, the most important sources of TCS in the environment 
are use of biosolids as agro-fertilizers [14]. The chemical properties of TCS suggest its possible 
bioaccumulation and further environmental persistence (Table 1). 
Currently, TCS and its degraded byproducts are found throughout the environment, including soil, 
surface waters, and human breast milk [14–18]. The continuous detection of TCS and its degradation 
products has led to debate on safety, effectiveness and regulation of TCS usage. Various studies shed light 
on the emerging health concerns related to the use of TCS, such as microbial resistance, dermal irritations, 
endocrine disruption, higher incidence of allergies, altered thyroid hormone metabolism and tumors 
development due to TCS and its by-products [19–21]. Unlike other emerging contaminants (ECs), such 
as organochlorine compounds, pharmaceutically active compounds (PhACs) and endocrine disrupting 
compounds (EDCs), TCS is not considered as a chemical pollutant with high priority concerns. Low 
acute toxicity and assumption of not to show chronic side effects, TCS usage is not well regulated [22,23]. 
This leads to widespread use of TCS in various household products, thus causing an increase in TCS 
concentration in the aquatic and terrestrial environment. 
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Table 1. General properties of TCS. 
CAS No. 3380-34-5 
Structure 
Molecular formula  C12H7Cl3O2  
Trade name 
Irgasan DP 300, FAT 80′023, CH 3565, GP41-353, 
Irgacare MP (the pharmaceutical grade of TCS,  
>99% pure) and Ster-Zac 
General classification Non-prescription compound 
Possible use Antimicrobial, antiseptic and disinfectant 
Nature Hydrophobic 
Molecular weight 289.54 
Dissociation constant (pKa) (20 °C) 8.14 
Henry constant (Hc) (atm mol−1·m−3) 1.5 × 10−7 (25 °C) 
Octanol-water Partition coefficient (log Kow) 4.76 
Sorption coefficient (Koc) 18408 
Solubility 12 mg·L−1 (25 °C) 
Vapor pressure 5.2 × 10−6 Pa (mm Hg at 20 °C) 
Bioconcentration factor (BCF)-  2.7–90 (aquatic organisms) 
Photodegradation (half-life in  
aqueous solution) 
41 min 
Biodegradation (half-life in aerobic soil) 18 days 
Biodegradation (anaerobic condition) No degradation within 70 days 
Degradation products of TCS Methyl TCS, dioxins, chlorophenols, chloroform 
Similar antimicrobial activity of TCS to antibiotics and its toxicity data demand regular monitoring 
of its concentration in the environment, along with its safe and regulated use in the consumer products. 
This article provides a comprehensive literature review on TCS, its occurrence in wastewaters, 
biosolids, aquatic and terrestrial environment, its removal potential, toxicity levels in humans, wildlife 
and other aquatic organisms, its bioaccumulation potential and intermediate products. The review also 
addresses the research gaps in concerns related to long term exposure to TCS. 
2. Physico-Chemical Properties of TCS Affecting Removal 
The removal of organic substances, such as TCS after release into environment depends on various 
physico-chemical properties of the compound. For instance, the sorption of organic compounds on sludge 
during wastewater treatment processes plays an important role. Depending on their log Kow values,  
the hydrophobic substances may adsorb onto settled sludge during primary sedimentation step in 
WWTP. The different physico-chemical characteristics of TCS governing its removal efficiency in 
conventional activated sludge treatment plants are given in Table 2. As evident from Table 2, the 
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adsorption potential of TCS is high due to a high log Kow. The high Kow value of TCS is also indicator 
of its bioaccumulation potential. Another important property governing the removal of organic 
substances is their volatility. Triclosan is also non-volatile (5.3 × 10−4 Pa at 20 °C) and is moderately 
soluble in water (10 mg·L−1 at 20 °C). Moreover, it does not hydrolyze easily [24]. Normally, the 
substances with a Henry’s constant (Hc) ≥ 10−3 atm·mol−1·m−3 will easily be removed by volatilization. 
Hence, the volatilization losses of specific substances during wastewater treatment can be predicted 
based on Henry’s constant value and Hc/Log Kow ratio [11]. 
Table 2. Removal potential of TCS during wastewater treatment process depending on 
different physico-chemical properties. 
Physico-Chemical Property Removal Potential of TCS 
Adsorption potential 
Log Kow ≤ 2.5 Low sorption potential 
2.5 < Log Kow < 4 Medium sorption potential 
Log Kow ≤ 4 High sorption potentialTCS 
Volatilization potential  
Hc > 1 × 104 and Hc/Log Kow >1 × 109 High volatization potential 
Hc < 1 × 104 and Hc/Log Kow <1 × 109 Low volatization potentialTCS 
The removal potential of TCS is given with a superscript; Hc/Log Kow ratio of TCS is 8.67 × 1014. 
TCS is a chlorinated phenoxyphenol with a pKa of 8.1 and is photodegradable into its photostable 
phenolate form (Figure 1). The phenolate-triclosan predominates when the natural water pH > 8.1 and  
it converts into its neutral phenolic form if the water pH is below 7.9. In addition to pH, co-occurrence 
of dissolved compounds such as metals and organic matter may possibly affect photosensitivity of  
TCS [24]. Hence, the complex matrix of wastewater affects the efficiency of photodegradation of TCS 
in WWTP [25]. 
3. Current Scenario of TCS Use and Safety 
Generally, TCS comes in the form of white powder. TCS has a weak aromatic, phenolic scent as it 
is a chlorinated aromatic compound. Ever since its invention, TCS has been widely used in numerous 
consumer products as illustrated in Figure 2 [6,8,10,12,26]. It is used as an active ingredient in dental 
products since 1980s in Europe and the mid-1990s in the United States after approval by the Food and 
Drug Administration [27]. More specifically, TCS is used in numerous personal care products, such as 
toothpastes, antibacterial soaps (bars and liquids), dishwashing liquids, deodorant soaps (bars and liquids), 
cosmetic and antiseptic products, and antiperspirants/deodorants [28]. Triclosan is also used in other 
consumer products, such as kitchen utensils, toys, bedding, clothes, fabrics, and trash bags. 
  
Int. J. Environ. Res. Public Health 2015, 12 5661 
 
 
 
Figure 1. Molecular structures of TCS and its environmental transformation product, methyl-TCS. 
 
Figure 2. Various applications of triclosan. 
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The concentration of TCS recommended by various government agencies to be used in various 
consumer products is given in Table 3. In 1989, the European Community Cosmetic Directive 
approved TCS usage as a preservative in cosmetics and toiletries up to 0.3% [28]. According to FDA, 
up to 0.3% TCS is permitted in toothpaste [29]. Similarly, as per the National Library of Medicine’s 
Household Product Database, TCS concentrations were reported to range from 0.1% to 0.3% in liquid 
hand soaps [30].  
Table 3. Recommended levels of TCS in various consumer products (Adapted from [25]. 
Type of TCS-Based Product  TCS Concentration (%) Reference 
Oral care products 
Toothpaste 0.3 [29] 
Mouth wash solutions 0.03 [31] 
Dermally applied products (rinse off) 
Skin cleansers 0.3 [28] 
Liquid hand soap 0.1–0.45 [32] 
Dishwashing detergent 0.1 [30] 
Dermally applied products (leave on) 
Body lotion 0.3 [28] 
Facial Moisturizer 0.3 [28] 
Deodorant/antiperspirants 0.3 [28] 
According to the FDA monograph for health care antiseptic drug products, which covered antibacterial 
soap products containing TCS, the recommended limits are up to 1% TCS for use in antiseptic washes 
and surgical hand scrubs in health care settings [33]. According to Governmental regulations in the 
European Union (EU) and the United States, only specified amount of triclosan can be used in some 
cosmetic and PCPs. 
TCS possesses a broad range of antimicrobial activity that encompasses several, types of non-
sporulating bacteria and a few fungi, such as Plasmodium falciparum and Toxoplasma gondii [19,34]. 
At low concentrations, TCS inhibits the growth of microorganisms; at higher concentrations, it kills 
microorganisms. Different microorganisms show varied response to TCS as provided in Table 4. 
Triclosan blocks the active site of enoyl-acyl carrier protein reductase enzyme (ENR) thus impairing the 
production of bacterial lipids [35]. In consequence, cell membranes are not properly produced and 
bacterial proliferation stops. Therefore, only a small TCS dose is required to inhibit bacterial growth. 
As humans lack ENR enzyme, TCS has been considered harmless to them.  
Studies carried out by FDA found that TCS-fluoride paste prevented tooth deformities, such as 
gingivitis, tartar and plaque in a way that was superior to fluoride-only toothpastes. Over the last 30 years, 
TCS has also been successfully used as an antimicrobial agent in hospitals and for other biomedical 
purposes. The successful control of methicillin-resistant Staphylococcus aureus (MRSA) outbreaks  
in several clinical settings using TCS based products [36,37]. This led to the recommendation of 
showering/bathing with 2% TCS for the decolonization of patients whose skin is carrying MRSA [38]. 
However, susceptibility of MRSA strains to TCS has changed little over the last decade [39]. Later on 
there has been no relation found between TCS response in MRSA and other strains of S. aureus and 
antibiotic susceptibility or resistance [40].  
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Table 4. Different microorganisms affected by the antimicrobial action of TCS. 
Target Microorganisms Effective Concentrations Reference 
Most sensitive strains 
Staphylococci, some Streptococci, some mycobacteria, 
Escherichia coli, Klebsiella pneumonia, Klebsiella spp., 
Enterobacter spp., Acinetobacter spp., Proteus spp.  
and Proteus mirabilis, Plasmodium falciparum,  
Toxoplasma gondii 
0.01 mg·L−1 to 0.1 mg·L−1 
[33]  
[19] 
Less sensitive strains   
Methicillin-resistant Staphylococcus aureus (MRSA) strains 0.1–2 mg·L−1 [40,142] 
Enterococci - [49] 
Highly resistant strains 
Pseudomonas aeruginosa,  
Clostridium difficile  
- [49,143] 
The American Medical Association (AMA) has raised concerns about the use of TCS and some 
other antimicrobial agents in consumer products [41]. The AMA has encouraged the FDA to study the 
issue on the safety and effectiveness of antimicrobials including TCS. The progress of the current FDA 
evaluation will be monitored by the AMA on regular basis. The AMA also indicated that further 
research is required on the introduction of antimicrobials in massive consumer products. In 2009, the 
American Public Health Association (APHA) proposed that it would recommend the banning of TCS 
for household and non-medical uses. However, no further action has been taken as yet. Regardless of 
current efforts to review and regulate the proper use of TCS, a scientific debate lingers on its potential 
adverse impact on human health, environment and potential association to microbial resistance. 
4. Emergence of Microbial Resistance to TCS 
The overuse of anti-microbial products may lead to increased resistance among bacteria. 
Considering the published studies, there is a dilemma whether TCS does or does not encourage the 
development of antibiotic resistance. Triclosan-resistant bacteria can be produced readily by their in 
vitro exposure to increasing TCS quantities and the consequent development of resistant colonies [42]. 
The mechanism of microbial resistance to TCS has been described by various researchers [43,44]. 
According to the authors, the resistance can be attributed to: (1) overproduction of 
targets/amplification or; (2) modification of target. Gomez-Escalda et al. [45] found that a combination 
of membrane impermeability and efflux were responsible for the increased insusceptibility of E. coli 
isolates to TCS. Various studies demonstrated the development of microbial resistance following exposure 
to TCS [44,46,47]. Reiss et al. [48] described the induction of expression of an efflux pump in P. 
aeruginosa following TCS exposure, resulting in high-level resistance to TCS and the antibiotic, 
ciprofloxacin. In E. coli, resistance can be attributed to either overexpression of the TCS target enzyme 
enoyl reductase or to changes in cellular permeability [49]. The most resistant bacteria have slow 
growth rate as compared to sensitive bacteria. On the contrary, E. coli resistant to TCS actually possess 
enhanced growth rates. The intrinsic resistance of P. aeruginosa to TCS can be attributed to: (1) a non-
susceptible enoyl reductase; (2) an outer membrane permeability barrier or; (3) pumping of the drug 
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from the cell interior to its exterior [50]. The latter has been stated as the major reason for TCS 
insusceptibility [51,52] in P. aeruginosa. MRSA strains, meanwhile, may or may not show decreased 
sensitivity to triclosan [50,53]. Study conducted by Fan et al. [54] demonstrated that all S. aureus 
strains with decreased sensitivity overproduced the enzyme Fab I by 3–5 fold and moreover, mutations 
in Fab I were found in the most resistant strains. 
Major concern is that the mode of action of TCS and its target site in the microbes is similar to 
antibiotics. The enzymes enoyl reductase (product of Fab I among Gram-positive and Gram-negative 
bacteria and Inh A in Mycobacterium e.g., M. smegmatic and M. tuberculosis) involved in fatty acid 
biosynthesis are the targets for a number of structurally unrelated drugs, including TCS. For instance, 
isoniazid an antibiotic used to treat tuberculosis that targets the same enzyme system [55]. Thus, TCs 
belongs to the group of drugs, such as isoniazid (tuberculosis) and diazoborine (experimental 
antibiotic) which target the enzyme enoyl reductase. Hence, a mutation in the enzyme may lead to 
resistance to TCS and these drugs. The overuse of TCS may result in the development of cross-resistance 
to antibiotics, and thereby the emergence of bacterial strains resistant to both TCS and antibiotics [56].  
The laboratory studies play an important role in evaluating mechanisms of action and resistance to 
biocides, including TCS. These studies are mostly related to a wide range of medical applications [49,57]. 
Various researchers have purported to demonstrate a correlation between the use of biocides including 
TCS and antibiotic resistance [55,58,59]. On the contrary, few authors advocated that TCS use should 
be regulated as all other biocides [8,60]. There was no relationship found between TCS application and 
antibiotic tolerance in methicillin-resistant Staphylococcus aureus and P. aeruginosa during a 10 year 
study conducted by [32]. Marshall et al. [61] reported no differences in overall titers of bacteria or 
frequencies of antibiotic resistance in a snap-shot investigation among homes using or not using 
bactericide products. Similarly, a comprehensive study by Cole et al. [62] found no relationship 
between the use of biocides including TCS and antibiotic resistance in homes with use/no use of 
biocidal agents.  
There was a concern that the use of TCS in dental hygiene products results in the development of 
TCS-resistant bacteria that are less sensible to common antibiotics. In view of this, an expert panel 
review concluded that there was no evidence of resistance development in the opportunistic or pathogenic 
microorganisms following the exposure to TCS [63]. The interim use of TCS containing dental 
hygienic products does not affect the stable microflora of the mouth or changes the susceptibility of 
Streptococci to antibiotics. However, chronic exposure to TCS demonstrated less significant decrease 
in antibiotic susceptibility in dental bacteria [64]. Usually, the introduction of bacteriostatic 
compounds to hinder plaque growth is seen as necessary [65]. Although TCS resistance in laboratory 
experiments may be linked with changes in antibiotic susceptibility, but comprehensive environmental 
investigations have not yet clearly established any relationship between TCS usage and antibiotic 
resistance. It is now well known that laboratory findings do not always apply in the real world 
environment [42].  
In general, bacterial resistance to disinfectants is not a new phenomenon. The phenomenon of 
decreased susceptibility to various disinfectants was being described over a century ago by various 
researchers as thoroughly reviewed by Russell, [66], before the introduction of TCS. The study conducted 
by Tan et al. [67] indicated that resistance to TCS and other biocides is increasing. This conclusion was 
generally based upon minimum inhibitory concentrations (MIC) in laboratory experiments rather than 
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bactericidal estimations. There might not be a correlation between a poor rate of kill and sensitivity at 
MIC level [49]. The use of MIC investigation to study emerging bacterial resistance is important as it can 
indicate a trend towards some resistance properties [40,68]. As resistance develops in a step-wise manner, 
it is judicious to conserve use and continued surveillance of susceptibility to antimicrobials. 
5. Toxicity of TCS 
Triclosan possesses broad-spectrum antimicrobial action and has been classified as a Class III drug 
(compounds with high solubility and low permeability) by FDA [69]. Due to environmental concerns, 
TCS was declared as Priority Existing Chemical for full assessment under the Industrial Chemicals 
(Notification and Assessment) Act, 1989 (the Act) in the Chemical Gazette of 6 May 2003 [70]. Some 
signs of it have been already reported as TCS was not only found in WWTPs, but even in urine, 
plasma and breast milk in humans [20,71,72]. Studies have thus yielded contradictory findings 
regarding links between TCS and adverse health impacts in humans and animals.  
5.1. Toxicity in Humans 
Absorption, distribution, metabolism and excretion are rapid in the case of TCS in human body. 
TCS is metabolized to glucuronide and sulfate conjugates (phase II metabolism) and are primarily 
excreted via urine. These hydrophilic conjugates of TCS limit the bioaccumulation of TCS. Some studies 
indicated that TCS is comparatively non-toxic to humans and other mammals. Conversely, studies 
indicated that TCS exposure resulted in contact dermatitis, or skin irritation [73]. A photo-allergic 
dermatitis (PACD) reaction can be triggered when the skin comes in contact with TCS and is further 
exposed to sunlight [74]. PACD can result in symptoms, such as eczematous rash on the body parts 
with combined TCS and sunlight exposure. According to the claims made by various manufacturers of 
TCS-containing toothpaste and soaps, the active ingredient continues to work even up to 12 h after use. 
This prolonged exposure to TCS in turn increases the risk of PACD.  
Triclosan has been found in urine, plasma, and breast milk of humans [16,20,75,76], but typically 
without attribution to specific sources of TCS exposure. High levels of TCS were found in 60% of 
human milk samples indicating the absorption potential of TCS into the body [15]. According to 
National Health and Nutrition Examination Survey (NHANES) data collected during 2003–2004, TCS 
was found in 75% of the analyzed urine samples [76,77]. The urinary data were collected for adult men 
and women and children between the ages of 6 and 11. NHANES is an ongoing annual survey 
conducted since 1999 by the US Centers for Disease Control and Prevention (CDC) aimed to collect 
data on selected chemicals, including TCS. This data is used to evaluate the nutrition quality and 
general health of the US population. Moreover, due to lipophilic nature of TCS, it may bioaccumulate 
in fatty tissues. Nevertheless, no study until date has established the carcinogenic, mutagenic, or 
teratogenic effects of TCS. 
Another area of concern is related to the hypothesis that TCS augments the production of 
chloroform. A study carried out by Fiss et al. [78] described that TCS may involve in the generation of 
chloroform, under certain conditions can almost double the chloroform formation in the drinking water 
treated with chlorine. On the contrary, studies [79] showed that there was no production of measurable 
quantities of chloroform within a normal tooth-brush when using toothpaste containing TCS and 
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normal chlorinated drinking water. According to US EPA classification, chloroform is a possible 
human carcinogen. As a consequence, there was a campaign in UK underlining the potential of TCS to 
cause cancer, although Hao et al. studies [79] revealed that the amount of chloroform generated was lower 
in volume. Meanwhile, TCS in household dishwashing soaps reacts with chlorinated H2O to produce 
significant quantities of chloroform, a probable human carcinogen [80]. 
5.2. Toxicity in Animals and Other Organisms 
The toxic effects of TCS were also studied in various animal models. For instance, its negative 
effect on the metabolism of thyroidal hormones causes hypothermia and an overall depression of the 
central nervous system (CNS) of mice [81]. The exposure to 0.03 mg·L−1 TCS was associated with 
induction of the expression of the metamorphic genes in tadpoles, which induced their premature 
metamorphosis [82]. Similarly, the study carried out by Kumar et al. [83] interrelated TCS exposure 
with decreased sperm production in male rats. The authors proposed the hypothesis that TCS blocks 
the metabolism of thyroid hormone as it presents a structure similar to the thyroidal hormone in 
regards to the binding of the specific receptors. Later, the endogenous hormones cannot bind to the 
occupied receptors.  
Its close structure resemblance to certain estrogens triggered masculinization of secondary 
characters in rice fishes [84]. A recent study by James et al. [85] pointed out that TCS can inhibit the 
estrogen sulfotransferase activity in sheep placenta which would cause negative effects in the fetus 
development. Although toxicity reports in humans from chronic usage of PCPs containing TCS as an 
active ingredient are not available, still it has been widely studied in laboratory animals. During 
chronic oncogenicity studies in mice, rats, and hamsters, treatment-related tumors were found only in 
the liver of male and female mice [23]. Application of the human relevance framework advocated that 
these tumors arose due to a mode of action which is not considered to be pertinent to humans [23]. 
However, Yueh et al. [86] found that long term exposure to TCS in mice enhances hepatocellular 
carcinoma. This mechanism of TCS induced liver carcinoma in mice and it should be evaluated as 
these findings strongly support the relevance of TCS toxicity to humans.  
Studies have also demonstrated that TCS accumulates in mice tissue with bioaccumulation factors 
of 3700–8400 [87]. This data indicates that fish contains concentrations thousands of fold higher than 
those found in the water column. Moreover, the bacterial transformation product of TCS in 
wastewater, methyl TCS is relatively lipophilic and stable in the environment, making it more likely to 
bioaccumulate in fatty tissue and will not photodegrade [88]. The lipid-based concentrations of methyl 
TCS detected in fish were considerably higher than the concentrations in lake water, indicating 
significant bioaccumulation of the compound. For aquatic organisms, the potential uptake mechanisms 
of lipophilic contaminants are direct uptake from water through exposed surfaces, mainly gills 
(bioconcentration), and also through the consumption of food (biomagnification) [21]. James et al. 
[89] demonstrated that demethylation of methyl TCS was slower than TCS conjugation in cattle fish. 
The bioaccumulation and slow conversion of methyl TCS in lower level consumers could serve as 
potential carriers of triclosan from the environment to higher level consumers in food chain. 
The structure and the function of algal communities in ecosystems receiving treated wastewater 
effluent may be affected by TCS contaminated wastewaters [90]. These alterations may result in shifts 
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in nutrient processing capacity and natural food web structure of these streams. TCS was also 
identified as the responsible key pollutant for the observed effects on growth of the green algae, 
Scenedesmus valuolatus under realistic exposure conditions [91]. Various studies investigated the 
toxicity of TCS on higher aquatic organisms [92–95]. Acute toxicity values ranged from 1.4 to 3000 
μg·L−1 with EC50 values for crustaceans (Daphnia magna mortality at 390 μg·L−1), insects (Chironomus 
tentans survival at 3000 μg·L−1), fish (Pimephales promelas mortality at 260 μg·L−1), higher plants 
(Lemna gibba growth inhibition at 62.5 μg·L−1) and microalgal species (Scenedesmus subspicatus growth 
inhibition at 1.4 μg·L−1, Skeletonema sp. at 66 μg·L−1). Moreover, the standard test organism, Selenastrum 
capricornutum (growth inhibition at 4.7 μg·L−1) was reported to be 30-fold more sensitive to TCS than 
the bacterium Vibrio fischeri (bioluminescence inhibition at 150 μg·L−1) [96]. The microalgae were 
found to be the most sensitive organism to TCS [92,94,97]. With the increasing concentrations of TCS 
in the environment, bacterial strains are more likely to adapt by developing resistance [59]. TCS has 
various important medical applications, thus the future goal must be to retain these important 
applications while eliminating the unnecessary ones for its safe use.  
All toxicity studies on TCS highlight the risks and suggest ban on TCS usage. In consequence, the 
FDA proposed, for comprehensive assessment of TCS toxicity on human health and animals, to 
regulate its further usage in consumer products until more information is available. Even though this 
proposal does not include environmental fate of TCS, this factor should be included in complete 
profiling of any chemical introduced into consumer products. In this sense, in 2010, more than 80 
organizations petitioned EPA to ban TCS usage beyond pesticides. Minnesota has banned sale of any 
cleaning product (soaps) that contains triclosan on 16 May 2014. This ban makes the most 
manufacturers to phase out triclosan until early 2017. In 2013, FDA announced that final action on 
TCS usage in soaps will be taken by 2016 across the world. To complete the North American scenario, in 
Canada, approximately 1730 products including personal care products, cosmetics and health products 
containing triclosan were reported in 2011. Some reports indicate that triclosan would be a wide ranging 
contaminant in Canada. Therefore, from 2015 on, Health Canada is in the process to ban TCS.  
6. Occurrence of TCS in Aquatic and Terrestrial Environment 
Incomplete removal of TCS from WWTPs and the applications of TCS laden biosolids into agricultural 
soils, leads to TCS being distributed in aquatic and terrestrial environment. Table 5 shows the 
prevalence of TCS in different environmental compartments worldwide. Environmental concentrations 
of TCS varied with surface water type (lake/river/streams with known input of raw wastewater) 
ranging from 1.4–40,000 ng·L−1; sea water <0.001–100 ng·L−1; sediment (lake/river/other surface 
water) <100–53,000 μg·kg−1 dry weight (dw); sediment (marine) 0.02–35 μg·kg−1 dw; wastewater 
influent 20–86,161 ng·L−1; wastewater effluent 23–5370 ng·L−1; biosolids from WWTP 20–133,000 
μg·kg−1 dw; activated/digested sludge 580–15,600 μg·kg−1 dw; pore water 0.201–328.8 μg·L−1 [96]. 
Triclosan is commonly detected in aquatic and terrestrial environments [14,98,99]. TCS is generally 
dumped through consumer products [100] and finally finds its way into the WWTPs. The occurrence 
of TCS along with other organic contaminants has been reported in Canadian municipal sewage sludge and 
biosolids [17,101,102]. TCS has also been identified in drinking water in certain geographical  
regions [103,104]. The degradation product of TCS, methyl TCS (12 μg·L−1) was found in one of the 22 
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drinking water samples from Barcelona [105]. Although WWTPs are generally highly effective in 
removing TCS, a small percentage of the antimicrobial is usually discharged with effluent into receiving 
waters. Thus, the two main sources of TCS release into the environment are: (1) discharge of WWTP 
effluent into receiving waters; and (2) land application of biosolids containing residues of the antimicrobial. 
The efficiency of WWTP for TCS removal has been observed with an average median removal 
efficiency of 90% [106,107]. TCS was found to be readily degraded under aerobic conditions but was 
observed to be resistant to degradation under anaerobic conditions [12]. The results of the field 
measurements from a Swiss WWTP have indicated that during the elimination process: 79% of TCS 
was biologically degraded, 15% was sorbed to sludge and 6% left the plant in the final effluent at a 
concentration of 42 ng·L−1 [6]. These results are in concordance with studies conducted at various 
WWTPs in Germany, where 4%–10% of TCS remained dissolved in effluent [10]. Mostly, WWTP 
influent concentrations of the TCS range from 1.86 to 26.8 μg·L−1 with effluent concentrations ranging 
from 0.027 to 2.7 μg·L−1 [14,108,109]. Despite the high removal rates reported for TCS,  
Yang et al. [110] studies identified the formation of toxic byproducts during oxidation of TCS.  
Table 5. TCS sourcing in some of the prominent environmental compartments worldwide. 
Source Sampling Source Country Concentration of TCS  Reference 
Surface waters Natural streams/rivers USA Up to 2.3 μg·L−1 [88,108] 
  Switzerland 0.074 μg·L−1 [111] 
  Germany 0.01 μg·L−1 [4] 
  Australia 0.075 μg·L−1 [112] 
  
Japan  
China 
0.0006–0.0059 μg·L−1  
0.011–0.478 μg·L−1 
[144]  
[113] 
 
Streams with inputs of raw 
wastewater 
Switzerland 0.011–0.098 μg·L−1 [6] 
  USA 1.6 μg·L−1 [5] 
 Estuarine waters USA 0.0075 μg·L−1 [143] 
Sediment Fresh water Switzerland 53 μg·kg−1 [6] 
  Spain 35.7 μg·kg−1 [122] 
 Estuarine USA 800 μg·kg−1 [117] 
 
Marine  
River water 
Spain  
China 
0.27–130.7 μg·kg−1  
50–1330 μg·kg−1 
[145]  
[114] 
During 1999 to 2000, US Geological Survey detected TCS in 57.6% of streams and rivers sampled, 
at concentrations ranging from below the detection limit up to 2.3 μg·L−1 [88]. In addition, due to the 
partial removal efficiency of WWTPs in effluent, TCS exhibits a tendency to accumulate and persist in 
biosolids. According to an assessment, up to 50% of TCS in WWTP influent will remain in biosolids 
in WWTPs even after activated sludge treatment in combination with anaerobic biosolids  
digestion [14,107,114]. The concentrations of TCS in aquatic environment is governed by various 
factors, such as the TCS load in effluent, physical and chemical properties of TCS, characteristics of 
the aquatic ecosystem  (pH, sediment density and organic matter content, water flow and velocity, 
depth), and even season and intensity of sunlight [99,100,115]. Despite the recent ban on addition of 
triclosan in daily use products, lower efficiency of WWTP to degrade it results in its accumulation in 
biosolids and hence release into the environment. The highest concentration detected 40,000 ng·L−1 are 
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still half of the lowest-observed-effect concentration reported for some fishes. However, taking into 
account that triclosan is in use since only few years and its derivatives are much toxic and very 
persistent, the regulations reducing its use seem to be the most accurate decision to prevent 
environmental consequences. 
 
7. Degradation of TCS 
Table 6 provides the concentrations of TCS detected in different organisms. This antimicrobial 
compound has demonstrated a tendency for bioaccumulation in aquatic species [116] and it can persist 
in aquatic ecosystems for extended periods of time. TCS prevalence in environment mandates  
monitoring in surface water. Triclosan has been detected in 30-year-old sediment from Greifensee Lake in 
Switzerland [6]. This study provided evidence of the persistence of TCS in sediment and unravels the 
pattern of TCS usage.  
Table 6. Detected concentrations of TCS in different organisms. 
Organisms Species/Sample Type Sampling Site TCS (μg·kg−1) Reference 
Algae 
Filamentous algae 
(Cladophora spp.)/Whole 
organism 
Receiving stream for the city 
of Denton (TX, USA) WWTP 
(1) 100–150  
(2) 50–400 
[146]  
[144] 
Invertebrates 
Freshwater snails  
(Helisoma 
trivolvis)/Muscle 
Receiving stream for the city 
of Denton (TX, USA) WWTP 
50–300 [144] 
Vertebrates 
Rainbow trout  
(Oncorhynchus 
mykiss)/Bile 
(1) Upstream from WWTP, 
Sweden (caged);  
(2) downstream 2 km from 
WWTP (caged) 
(1) 710  
(2) 17,000 
[20] 
 
Breams, male  
(Abramis brama)  
(1) Bile  
(2) Muscle 
(1) River sites (Netherlands)  
(2) River sites (Germany) 
(1) 14,000–
80,000  
(2) 0.25–3.4 
[147]  
[148] 
 Pelagic fish/Plasma Detroit River (USA) 0.75–10 [149] 
 
Atlantic bottlenose 
dolphins (Tursiops 
truncates)/Plasma 
(1) Estuary, South Carolina  
(2) Estuary, Florida 
(1) 0.12–0.27  
(2) 0.025–0.11 
[150] 
 
Killer whale  
(Orcinus orca)/Plasma 
Vancouver Aquarium Marine 
Science Centre 
9.0 [150] 
 
Triclosan concentrations in sediment increased between the early 1960s after its introduction until 
the mid-1970s, reflecting steadily increased patterns of its use. Later, an opposite trend was observed 
from the mid-1970s until the early 1980s, during which period, an additional secondary treatment step 
was introduced into most WWTPs. However, due to the popularity and increased use of TCS, again 
from the early 1980s, increase in TCS concentrations was observed until the present time [6]. 
Nevertheless, the quite high amount of TCS present in the 30-year old sediment layer from 1970 to 
1971 showed that TCS degradation was very slow in the sediment. [117] also reported similar time line 
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profile for TCS spanning last 40 years for estuarine sediments in the USA. The environmental 
persistence of TCS in sediments indicates the fact that antimicrobial compounds can partition into the 
sediments and resist degradation processes under anaerobic conditions. Moreover, sediments are the 
final sink of the aquatic environment and the retention of TCS in this matrix would be precarious as 
there are eventual possibilities of being released back into the aquatic environment by bioturbation 
caused by organisms or through human dredging [118,119].Although TCS possesses high chemical 
stability and it is extremely resistant to high and low pH, it is found to be readily degraded in the 
environment through photodegradation. In laboratory samples, researchers have identified eight sub-
products of this photochemical process [120–126]. Under laboratory conditions, Latch et al. [21] 
observed TCS photoconversion to 2,8-DCDD with a yield of up to 12% at pH > 8 using different 
irradiation wavelengths. Authors compared the formation of  2,8-DCDD yield under laboratory 
conditions (purified water) with the river water spiked with the TCS. Comparable results between 
laboratory and realistic conditions confirmed that TCS was able to convert into 2,8-DCDD in sunlight-
irradiated water sources.  
Triclosan that persists in the secondary effluent after activated sludge treatment may be chemically 
transformed after discharge. In this sense, a disinfecting oxidant, sodium hypochlorite, a source of free 
chlorine is generally used in US for many purposes and could enter in contact with TCS. It is known to 
chlorinate the TCS phenol carbons in ortho, or para-positions generating three chlorinated TCS 
derivative (CTD) intermediate products: [78,122,127]. The light mediated degradation of CTDs to 
chlorinated dioxins is depicted in Figure 3. However, dioxin derivatives of TCS are not of public health 
concern mainly due to the low efficacy of direct photolysis [123]. Similarly, chloramination of TCS also 
forms the similar CTDs, although at a much lower rate than the free process [128]. Chlorinated 
derivatives of TCS, 4-Cl-TCS, 6-Cl-TCS, and 4,6-Cl-TCS were reported to be present in wastewater 
effluent [13,129]. Due to dispersal of TCS containing effluents in the streams, the CTDs have been also 
detected in the top levels of aquatic trophic chains [130], and as biomethylated analogues in fresh water 
samples downstream from a wastewater effluent as well as in carps living in it [131]. These results 
demonstrated that either CTDs are generated from TCS during wastewater disinfection with free 
chlorine or bypassing the standard treatments. CTDs are considered as an important environmental 
issue as they could may maintain or even increase the antimicrobial and endocrine-disrupting features, of 
TCS. Moreover, the CTDs, such as 4-Cl-TCS, 6-Cl-TCS, and 4,6-Cl-TCS are extensively reported to 
liberate dioxins under natural conditions of photolysis in water [87,132].  
The historical pattern of dioxin photoproducts of TCS and its chlorinated derivatives in sediment 
cores from the Mississippi river was reported by Buth et al. [132]. Another possible source of TCS 
derived dioxins comes from the solar irradiation of CTDs, leading to the formation of chlorinated 
dioxins. 2,8-DCDD and 2,4-dichlorophenol (2,4-DCP) are produced after photochemical degradation of 
TCS, when chemical by-products are exposed to UV radiation after the reaction of TCS with chlorinated 
H2O [78]. 2,4-DCP is further chlorinated to produce 2,4,6-trichlorophenol [133]. The chlorophenol 
intermediates are subsequently transformed to chloroform and trihalomethanes [134]. The mechanisms 
of CTDs transformation to chlorophenols and further to chloroform and trihalomethanes is given in 
Figure 4. 
The repeated exposure to chlorine in water treatment facilities can chlorinate TCS. Chlorinated  
TCS is discharged from a WWTP, and sunlight can convert it into more toxic dioxins [135]. According 
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to U.S.EPA, 2,4-DCP is a priority pollutant, and is considered to be toxic to fish and other aquatic 
organisms [56,136]. 2,4-DCP is used in the manufacture of certain pesticides, antiseptics, and disinfectants. 
Moreover, in the presence of solar radiation, the 2,4-DCP further breaks down and may produce more 
highly chlorinated dioxins [137]. 
 
Figure 3. Photolytic degradation of chlorinated TCS derivatives (CTDs) to chlorinated dioxins. 
Meanwhile, a study by Latch et al. [123] concluded that dioxin compounds formed from TCS are 
not of public health concern due to the low concentrations of reactive oxygen species (ROS) in natural 
waters and low efficacy of direct photolysis of TCS. Several bacteria such as, Pseudomonas, 
Burkholderia or Sphingomonas can degrade them in natural environments to carbon dioxide and 
chlorine [138,139]. Son et al. [140] reported that degradation of TCS through titanium dioxide 
photocatalysis is mediated by radicals that enhance the degradation of intermediary dioxins. Moreover, 
the oxidative process is maximized by hydrogen peroxide [141]. When TCS remains isolated from 
biotic interaction and is maintained between pH 4–9, it is stable even at 50 °C. In an aqueous solution 
at 25 °C and pH 7, TCS undergoes faster degradation mediated by light, reaching 50% in around 41 
min. During this reaction, mainly 2,4-dichlorophenol (2,4-DCP) is produced within 4 h after treatment.  
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Figure 4. Mechanisms of TCS conversion to its intermediate products: chlorinated TCS 
derivatives, chlorophenols and chloroform and trihalomethanes. 
TCS is readily susceptible to degradation through photolysis in aqueous media with half-life that 
ranges from <1 h in abiotic conditions, to around 10 days in fresh water bodies. Moreover, its aerial half-
life has been estimated to be 8 h based on reaction of TCS with photo-chemically produced hydroxyl 
radicals. Even though the detected concentrations as of now may not be toxic, but continuous accumulation 
of TCS and its by-products in the environment could reach the threshold limit which can affect all 
levels of the animals in the food chain.  
8. Conclusions and Future Prospects 
The ubiquitous use of triclosan and its consequent entry into the environment is of concern due to 
the effects it could produce if no regulations prevent its accumulation during the next decades. It and 
its derivatives are already present in measurable quantities, which may potentially affect water quality, 
impact on ecosystem and human health. Contamination of TCS has been detected in different 
environmental matrices including terrestrial, aquatic and biosolids resulting from WWTPs. TCS has 
also been found in drinking waters. There are concerns that the widespread use of TCS in various 
applications might lead to a preferential selection for microbial resistance to antibiotics. Microbial 
resistance has become an increasingly serious problem worldwide, and the continued use of biocides 
including TCS may exacerbate this problem. Increasing accumulation of TCS in the environment was 
also found to have adverse impacts on the growth of aquatic organisms. Taking into consideration the 
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environmental and health concerns of TCS, more efforts need to be carried out for the understanding of 
their distribution and fate in various environmental compartments, in particular, wastewater treatment 
plants and sediments which are the final sinks.  
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